Forest Laboratories ($FRX) faces another proxy battle as its annual investor meeting this summer looms. Icahn, the company's second largest shareholder, has been highly critical of the company's leadership. The deadline is again approaching to nominate alternative directors on the company's board, and Forest is negotiating to avoid a third proxy brawl. More